Bell Asset Management Ltd Has $4.68 Million Stake in Cencora, Inc. $COR

Bell Asset Management Ltd trimmed its stake in Cencora, Inc. (NYSE:COR) by 23.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,966 shares of the company’s stock after selling 4,625 shares during the quarter. Cencora accounts for 1.3% of Bell Asset Management Ltd’s portfolio, making the stock its 23rd largest position. Bell Asset Management Ltd’s holdings in Cencora were worth $4,677,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. IAG Wealth Partners LLC acquired a new position in Cencora in the 3rd quarter valued at approximately $30,000. Vermillion & White Wealth Management Group LLC boosted its stake in shares of Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares during the period. Cloud Capital Management LLC acquired a new stake in shares of Cencora during the 3rd quarter valued at $31,000. Caitlin John LLC purchased a new position in shares of Cencora during the 3rd quarter valued at $31,000. Finally, Westside Investment Management Inc. grew its holdings in shares of Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after acquiring an additional 70 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Cencora Trading Down 0.4%

Shares of NYSE:COR opened at $357.98 on Monday. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The stock has a market capitalization of $69.64 billion, a PE ratio of 43.03, a P/E/G ratio of 1.67 and a beta of 0.68. Cencora, Inc. has a 1 year low of $251.94 and a 1 year high of $377.54. The firm has a fifty day moving average price of $354.16 and a 200 day moving average price of $336.68.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. During the same period last year, the company earned $3.73 earnings per share. The business’s revenue was up 5.5% compared to the same quarter last year. Analysts expect that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is 28.85%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on COR shares. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a report on Thursday, January 22nd. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, February 5th. JPMorgan Chase & Co. raised their price target on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Barclays lifted their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Finally, TD Cowen boosted their price target on Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Eleven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cencora has a consensus rating of “Moderate Buy” and an average target price of $399.00.

Insiders Place Their Bets

In other Cencora news, EVP Elizabeth S. Campbell sold 3,351 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the completion of the transaction, the executive vice president owned 23,891 shares of the company’s stock, valued at $8,173,111.10. The trade was a 12.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the sale, the chief executive officer owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,220 shares of company stock valued at $5,282,867 in the last quarter. Insiders own 0.38% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.